Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Baldi

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|June 19, 2009
Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patientsBruno Vincenzi, Daniele Santini, Fotios Loupakis, et al.
Cancer Medicine|July 17, 2023
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centersPaola Zagami, Alessandro Comandone, Marco Fiore, et al.
Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.
Cancer|August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma GroupFederica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trialPiotr Rutkowski, Louie Gaston, Aneta Borkowska, et al.
Current Cancer Drug Targets|June 29, 2010
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)Daniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Critical Reviews in Oncology/Hematology|July 13, 2010
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational statusLorenzo Fornaro, Giacomo Giulio Baldi, Gianluca Masi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2023
Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical studySilvia Stacchiotti, Giacomo Giulio Baldi, Anna Maria Frezza, et al.
Clinical Sarcoma Research|April 19, 2013
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment optionsBruno Vincenzi, Anna Maria Frezza, Gaia Schiavon, et al.
Cancer Medicine|June 8, 2021
Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosisEdoardo Zanchetta, Chiara Maura Ciniselli, Annalisa Bardelli, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|June 19, 2009
Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patientsBruno Vincenzi, Daniele Santini, Fotios Loupakis, et al.
Cancer Medicine|July 17, 2023
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centersPaola Zagami, Alessandro Comandone, Marco Fiore, et al.
Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.
Cancer|August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma GroupFederica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trialPiotr Rutkowski, Louie Gaston, Aneta Borkowska, et al.
Current Cancer Drug Targets|June 29, 2010
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)Daniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Critical Reviews in Oncology/Hematology|July 13, 2010
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational statusLorenzo Fornaro, Giacomo Giulio Baldi, Gianluca Masi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2023
Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical studySilvia Stacchiotti, Giacomo Giulio Baldi, Anna Maria Frezza, et al.
Clinical Sarcoma Research|April 19, 2013
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment optionsBruno Vincenzi, Anna Maria Frezza, Gaia Schiavon, et al.
Cancer Medicine|June 8, 2021
Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosisEdoardo Zanchetta, Chiara Maura Ciniselli, Annalisa Bardelli, et al.
Pageof 4